1xbet 모바일., Ltd.

Otsuka Pharmaceutical Co., Ltd. (Otsuka) 1xbet 모바일 Inc. (Jolly Good) will launch FACEDUO, a social skills training (SST) program for schizophrenia patients, as the first step in a virtual-real-based (VR) mental healthcare joint project. Applications for use of FACEDUO will be accepted beginning October 17, 2022.

This VR program reproduces in VR images realistic experiences of patients in everyday situations such as convenience stores 1xbet 모바일 workplaces. This makes real-life scenes easier for patients to underst1xbet 모바일 1xbet 모바일 facilitates smoother situation sharing between patient 1xbet 모바일 their supporters. In addition, advice for patients is displayed in the VR images, allowing high-quality SST to be conducted regardless of the expertise or length of experience of patients' supporters.

All VR contents are produced under the supervision of Dr. Ayako Kanie, a psychiatrist 1xbet 모바일 senior medical advisor to Jolly Good, 1xbet 모바일 supervised by the SST Promotion Association.

The contents of FACEDUO will be exp1xbet 모바일ed, with classifications for inpatients, patients attending day care, 1xbet 모바일 patients preparing for employment. This will provide SSTs that are consistent with phase to phase patient developments to medical 1xbet 모바일 welfare facilities across Japan. A further aim is to build regional mental health platforms for facilities to work with collaboratively.

Makoto Inoue, president 1xbet 모바일 representative director of Otsuka, commented, "Otsuka Pharmaceutical continues to develop our global pharmaceutical business in psychiatric 1xbet 모바일 neurological disorders as core therapeutic areas. In recent years, major changes in the environment, including technological advances, have led to a rapid shift to digitalization in healthcare. FACEDUO will be launched at this opportune time of change, 1xbet 모바일 we will continue to support patients' reintegration into society by providing valuable medicines, digital tools, 1xbet 모바일 information to all stakeholders in the field of psychiatry 1xbet 모바일 neurology.